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Abstract
Background Mobile bearing (MB) total knee design has
been advocated as a means to enhance the functional
characteristics and decrease the wear rates of condylar total
knee arthroplasty (TKA). However, it is unclear if these
designs achieve these goals.
Questions/purposes We asked whether function of
patients or survivorship would be greater or complications
would be lesser in groups of patients with MB compared
with fixed bearing (FB) TKA. We also sought to describe
retrieval findings.
Methods We randomized 507 primary TKAs in 416 eli-
gible patients to receive MB (n = 252) or FB (n = 255)
devices from November 2001 to August 2007 (Investiga-
tional Device Exemption G000180, ClinicalTrials.gov
registration number NCT00946075). Patients were blinded
to treatment allocation. WOMAC Index, SF-12 Health
Survey, knee range of motion, and Knee Society scores
were collected and compared preoperatively and at 6, 12,
and 24 months postoperatively. We recorded device fail-
ures and complications until October 2009. Kaplan-Meier
survivorship was compared using the log rank test. Twelve
retrieved MB devices underwent pathologic analysis.
The minimum postoperative time was 2.2 years (mean,
5.9 years; range, 2.2–7.9 years).
Results We found no differences in mean clinical assess-
ment scores or mean score changes from baseline at any
postoperative interval through 2 postoperative years. Nine-
teen of the 252 MB and 13 of the 255 FB knees had
undergone revision of any component. Estimated survival at
6 postoperative years was similar for the two devices: 90.1%
(95% confidence interval [CI], 84.1–93.9) for MB and
94.2% (95% CI, 90.1–96.6) for FB. Two MB and no FB
tibial components were revised for loosening. There was one
case of MB insert dislocation. Retrieved MB devices dem-
onstrated no unexpected wear or mechanical device failures.
Conclusion We found no evidence of functional advan-
tage of the MB design. Survivorship was similar, although
the study is limited by short duration of followup.
Level of Evidence Level I, therapeutic study. See
Guidelines for Authors for a complete description of levels
of evidence.
Introduction
Implant designers have long recognized the kinematic con-
flict between wear-resistant conforming articular surfaces in
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TKA prostheses and the need to accommodate complex knee
motion patterns [7, 14]. In response to the problems of early
delamination and accelerated wear experienced with poly-
ethylene sterilized by gamma irradiation in air during the late
1960s [14, 42], development of high contact area rotating
bearing total knees began in the mid- to late 1970s.
Mobile bearing (MB) devices have enjoyed remarkable
commercial success [9–11] and are acclaimed for improved
functional rotation and stability [16, 21] and low wear rates
[2, 23, 32, 33] and when compared with fixed bearing (FB)
devices. However, these claims remain controversial and
have been largely unsupported by the peer-reviewed liter-
ature [20, 22, 36, 39]. Additionally, concerns remain about
the risks of bearing dislocation and fine particle debris
generation in MB devices [5, 13, 15].
We asked whether function of patients or survivorship
would be greater in groups of patients with MB than FB
devices of a multicenter randomized trial and whether MB
devices were associated with any unusual complications or
retrieval findings. Specifically, the purposes of this study
are to (1) compare functional scores in patients with MB
versus FB devices at 2 years postsurgery; (2) compare
survivorship with MB device and FB control device; (3)
identify complications; and (4) report retrieval findings.
Patients and Methods
Between November 2001 and July 2007, 423 patients with
noninflammatory degenerative joint disease of the knee
who had indications for primary TKA and met the inclu-
sion criteria (Table 1) were enrolled from 14 US centers
into an Investigational Device Exemption designed to
evaluate safety and effectiveness of an investigational MB
TKA system (Scorpio1 + PS MB prosthesis; Stryker
Orthopedics, Mahwah, NJ, USA) in comparison to a
commercially available FB system (Scorpio1 PS FB
prosthesis; Stryker) at 2 years postimplantation. A total of
507 TKAs (255 FB and 252 MB, as randomized) of
416 patients were ultimately included in the trial (Fig. 1).
The investigational Scorpio1 + PS Mobile Bearing Insert
and Osteonics Scorpio1 Total Knee PS Tibial Bearing
control insert are N2Vac gamma-sterilized UHMWPE
inserts, which differed slightly in their respective tibial
topography; the rotating platform design included a
reduced posterior profile identical to that of the commer-
cially available Scorpio1Flex bearing insert, whereas the
FB device used a more conforming raised posterior lip. The
same femoral component (Scorpio1 PS) was used for both
groups. All components were cemented. The protocol
called for replacement of all patellae. Investigative sites
underwent a qualification process including evaluation of
investigator expertise, research experience and personnel,
subject population, and institutional resources. Each
enrolled patient was randomized to a treatment arm after
collection of all preoperative data. Randomization was
centrally administered using randomization lists computer-
generated by a statistician, which were blocked by center
and whether the patient was scheduled for bilateral or
unilateral TKA in block sizes of four in 1:1 allocation ratio.
After confirmation of preoperative data and inclusion eli-
gibility, the sponsor assigned a patient identification
number and determined the device system assignment by
selecting the next system on the list. Patients undergoing
bilateral TKA (n = 74) were allocated to receive the same
device in both knees. Patients undergoing unilateral TKA
who later underwent primary TKA for the contralateral
knee were asked to enroll the second knee into the study
and allocated to receive the same device (n = 17). Par-
ticipating patients agreed to forgo knowledge of which
Table 1. Study inclusion and exclusion criteria
Inclusion criteria
Male or nonpregnant female scheduled for unilateral or bilateral
TKA procedure
Aged 21–80 years
Diagnosis osteoarthritis, traumatic arthritis, or avascular necrosis
Failed to respond to conservative treatment
Treatment with primary cemented TKA indicated
Collateral ligaments intact
Preoperative Knee Society clinical score \ 60 and functional
score \ 60
Gives valid informed consent
Exclusion criteria
Prior high tibial osteotomy, cruciate ligament reconstruction, or
patellectomy
Morbid obesity ([ 60% over ideal body weight [17])
Varus or valgus alignment deformity [ 45
Fixed flexion deformity [ 45
Active or suspected infection or malignancy of or about the knee
Immunocompromised or receiving steroids in excess of
physiological requirement
Severe osteoporosis, Paget’s disease, renal osteodystrophy, or other
systemic disease that at the investigator’s judgment would affect
subject’s welfare or overall outcome of the study
Bone stock compromised by disease or infection that cannot provide
adequate support/fixation to the prosthesis
Neurologic deficit that interferes with patient’s ability to limit
weightbearing or places an extreme load on the implant
Female who plans to become pregnant during course of the study
Known sensitivity to device materials
Has an existing TKA on the contralateral side less than 6 months
postoperatively
Patient undergoing unilateral TKA and expected to undergo TKA of
the contralateral knee within 6 months
Patient is a prisoner
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device(s) they had received until completion of the study;
however, investigators and assessors were not blinded to
treatment group (single-blind, open-label design). Baseline
characteristics (Table 2) and preoperative clinical scores
(Table 3) were comparable between the groups with the
exception of slightly increased average preoperative knee
flexion among the MB group (average difference 2.6,
p = 0.041). Minimum postoperative time was 2.2 years
(mean, 5.9 years; range, 2.2–7.9 years). The Institutional
Review Board at each center approved the study and all
patients gave informed consent before participation in the
trial. The study is registered at ClinicalTrials.gov under
registration number NCT00946075.
The Investigational Device Exemption was originally
designed and undertaken for the purpose of establishing
safety and effectiveness in an active-control design to
support a Premarket Approval application to the Food and
Drug Administration; as such, the sample size had been
designed to support a noninferiority analysis of a binary
composite success criteria with a lower confidence bound
margin of 10% at 80% power among the subset of uni-
lateral TKA cases. Because the current study constitutes
Eligible for 2-year functional evaluation
(n=185 patients / 231 knees)
♦ Excluded                      
Remained in study but functional 
evaluation not completed or data missing                    
(n=7 patients / 9 knees)
♦ Analyzed
(n=178 patients / 178 knees)*
Allocated to Scorpio+ PS Mobile Bearing                      
(n=211 patients/ 260 knees)
♦ Received intervention 
(n=205 patients / 252 knees)
♦ Did not receive intervention 
(n=6 patients / 8 knees)
•
•
Allocated to Scorpio PS Fixed Bearing
( n=218 patients / 263 knees)
♦ Received intervention                
(n=211 patients / 255 knees)
♦ Did not receive intervention     
(n=8 patients / 8 knees)
•
•
Eligible for 2-year functional evaluation
(n=184 patients / 228 knees)
♦ Excluded from analysis 
Remained in study but functional 
evaluation not completed or data missing                    
(n=1 patient / 1 knee)
♦ Analyzed
(n=183 patients / 183 knees)*
Randomized
(n= 429 patients / 523 knees )
Withdrawn from study before 2-year followup 
evaluation  (n=27 patients / 27 knees)
♦ Lost to followup (n=7 patients / 7 knees)
♦ Unwilling to return (n=2 patient / 2 knee)
♦ Unable to return (n=2 patient / 2 knee)
♦ Voluntary withdrew (n=6 patients / 6 knees)
♦ Death (n=1 patients / 1 Knees)
♦ Revised (n=9 patients / 9 knees)
Withdrawn from study before 2-year followup 
evaluation  (n=20 patients / 21 knees)
♦ Lost to followup (n=4 patients /4 knees)
♦ Unwilling to return (n=1 patient /1 knee)
♦ Voluntary withdrew (n=6 patients / 7 knees)
♦ Death (n=4 patients / 4 Knees)
♦ Revised (n=5 patients / 5 knees)
Fig. 1 Treatment allocation and patient followup to the primary analysis end point are shown by flow diagram.
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secondary aims/analyses of these data, we conducted
power analyses for comparison of functional measures with
the sample size available (416 knees of 416 patients
included in analyses of clinical outcome measures with
C 85% complete data at 2 years); 178 patients in each of
two groups would provide [ 80% power at two-sided
alpha = 0.05 to detect a mean difference with (SD =
assumed standard deviation) of 1 knee extension (SD =
2.8) [35], 5 knee flexion (SD = 14.6) [35], 3-point SF-12
component score (SD = 10) [51], 6-point WOMAC
domain score (SD = 20) [29], 6-point Knee Society
function score (SD = 18.3) [29], and 3-point Knee Society
clinical score (SD = 12.8) [29].
Clinical and functional status of patients were assessed
preoperatively and at 6 (± 1), 12 (± 2), and 24 (± 2)
months postoperatively using the WOMAC visual analog
scale version 3.0 [4] (pain, function, and stiffness domains,
100 points each; lower score corresponds to better outcome),
the SF-12 Health Survey [49] (mental and physical com-
ponents, 100 points each; norm-based scores are calibrated
to a population mean of 50 and SD of 10; higher score
corresponds to better outcome), the Knee Society scoring
system [25] (clinical and functional scores, 100 points each;
higher score corresponds to better outcome), and knee ROM
measurement (degrees active extension and flexion).
Ongoing surveillance for revisions and other operative
site-related adverse events was conducted until the time
that every patient in the study had completed the 2-year
clinical followup interval (October 2009). The severity of
each adverse event was classified by the reporting inves-
tigator as mild, moderate, or severe according to study
guidelines; the definition of severe was similar to the ICH
Good Clinical Practice guidelines definition of a serious
adverse event [24]. Two adverse events with missing
severity classification were classified by the principal
investigator by review of the adverse event report form. For
the purpose of this analysis we classified severe operative
site-related events as major complications and mild or
moderate operative site events as minor complications. The
protocol specified patients were withdrawn from further
followup after any occurrence of revision with the excep-
tion that patients with investigational devices continued to
be followed for as long as the investigational tibial com-
ponent remained in situ.
Standard AP, lateral, and merchant view radiographs of
the knee were also obtained at all intervals and every
2 years thereafter for the duration of the study. One of two
orthopaedic surgeon reviewers who were otherwise unas-
sociated with the study (MB, JA) reviewed each
postoperative radiograph for the presence of tibial com-
ponent subsidence, defined as settling or shifting of the
prosthesis in the cavity, and zonal radiolucencies [18],
defined as a lucent area C 1 mm in width seen parallel and
in close proximity to the device encompassing at least 50%
of the zone. Tibiofemoral (TF) angle [18] was measured
from the preoperative AP films by the independent
Table 2. Pre- and postrandomization characteristics of study group (n = 507 knees of 416 patients)
Characteristic Mobile bearing Fixed bearing p value
Number of patients/number of knees 205/252 211/255
Male/female* (number of patients [%]) 68 (33%)/137 (67%) 82 (39%)/129 (61%) 0.261
Age (years)*, 66 ± 9 67 (35, 81) 66 ± 9 68 (40, 83) 0.616
Body mass index (kg/m2)*, 31 ± 5 31 (20, 54) 31 ± 5 31 (21, 47) 0.321
Underwent unilateral/bilateral* procedure
(number of patients [%])
168 (82%)/37 (18%) 174 (82%)/37 (18%) 0.899
Diagnosis (number of knees [%])
Osteoarthritis 248 (98%) 246 (96%) 0.381
Avascular necrosis 0 (0%) 0 (0%)
Posttraumatic arthritis 4 (2%) 9 (4%)
Preoperative knee alignment
(degrees, varus/+ valgus),,§
5 ± 7 5 ± 7 0.357
6 (25, 16) 5 (24, +14)
Postoperative alignment
(degrees, varus/+ valgus),
5 ± 2 5 (5, 9) 5 ± 2 5 (2, 10) 0.215
Surgical approach (number of knees [%])
Medial parapatellar 140 (68%) 145 (69%) 0.981
Lateral parapatellar 1 (\ 1%) 0 (0%)
Subvastus 58 (28%) 59 (28%)
Midvastus 6 (3%) 7 (3%)
* Unit of analysis is n = 416 patients; results given as mean ± SD, median (range); unit of analysis is n = 507 knees; §tibiofemoral anatomic
alignment.
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reviewers (MB, JA); postoperative TF angle was measured
and reported by the local investigator as part of each fol-
lowup examination. Interobserver correlation of TF angle
measurement from standard view radiographs reportedly
ranges from r = 0.44 to 0.59 but assessment of radiolucent
lines is less reliable (Pearson’s r, range, 0.15-0.56) [3].
Interobserver reliability of subsidence measurement has, to
the authors’ knowledge, not been documented, although it
has been suggested that conventional radiographic mea-
surement is likely to overestimate true subsidence of tibial
components [45].
Revised investigational devices were retrieved accord-
ing to the established implant retrieval protocol of the
Cleveland Clinic and analyzed there by an independent
orthopaedic pathologist (TB).
Baseline characteristics were compared between groups
using the independent samples t-test for normally distrib-
uted data or the Wilcoxon rank sum test for nonnormally
distributed data or Fisher’s exact test for discrete data.
Average clinical assessment measures (knee extension and
flexion; WOMAC, SF-12, and Knee Society scores) were
displayed graphically over preoperative, 6-, 12-, and
24-month postoperative intervals and compared between
treatment arm groups at each interval using Student’s t-test
or Wilcoxon rank sum test as appropriate for the distribu-
tions. The postoperative change of each clinical assessment
measure from baseline to 12 and 24 months postopera-
tively was calculated for each patient (postoperative minus
preoperative value) and summarized as an average and SD
for each treatment group. Score changes from baseline
were normally distributed within each group for all mea-
sures. The differences between the groups of mean score
change were tested using the independent samples t-test,
and 95% confidence intervals for the estimated difference
between the groups were constructed from the t distribu-
tion. Borrowing from the principals of bioequivalence
testing, we then compared the 95% confidence limits for
the difference between groups of mean clinical change
from baseline to a minimum clinically important difference
(MCID) for each outcome measure [38]. MCID is the
smallest difference that represents a clinically meaningful
change and/or is perceptible to patients. MCID has been
established as 9 to 12 points for the 100-point domains of
WOMAC visual analog scale score [17, 47] and approxi-
mately 3 points for SF-12 mental and physical components
[50] but has not been formally established for Knee Society
score or ROM. Thus, as MCID, we chose 9 points for
WOMAC scores (each domain), 3 points for SF-12, and,
arbitrarily, 2 knee extension and 5 flexion and 9 points
for Knee Society clinical and functional scores. The prin-
cipal of confidence interval equivalence testing is that two
randomly allocated treatments can be considered clinically
equivalent if the 95% confidence interval for the difference
between groups lies wholly inside the limits of –(MCID)
and +(MCID) [6].
Survival probability for the FB and MB groups was
estimated using the Kaplan-Meier method with revision of
any component for any reason as the primary end point.
The log rank test with two-sided alpha = 0.05 was used to
test for differences of survival curves. Survival estimates
were also computed using a more sensitive end point
defined as revision of any component for any reason or the
earliest occurrence of any of the following radiographic
findings: zonal lucency size [ 3 mm, which was also
present at size [ 3 mm at one or more subsequent intervals
and/or had been documented as present in smaller size at
a previous interval (present for 11 knees); or lucency
C 5 mm seen in three or more zones of the same compo-
nent on any examination (one knee) or tibial component
subsidence [ 3 mm on any examination (one knee). Knees
without the event were censored on the date of the latest
clinical evaluation. A peculiarity of our data was that the
Table 3. Preoperative clinical status of 416 knees* (416 patients)
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Knee Society scores (100 points each)










* One randomly selected knee included from patients with bilateral
procedures (see Statistical Methods); all results given as mean ± SD,
median (range).
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latest revision of a MB device occurred at 6.9 years post-
operatively with very few (two FB, nine MB) knees left in
the analysis (Fig 1); as a result, the final survival estimate
for the MB group was spuriously low with wide confidence
intervals (survival estimate 81.1% with 95% CI, 56.0%–
92.7% for the primary end point) [12]. We handled this by
including numbers left on the plot and citing the survival
estimates calculated at 6 postoperative years, which were
calculated with [ 50 left in the analysis [31]; all cases
were included in the Kaplan-Meier plot and log-rank test.
Rates of major and minor complications were calculated as
incidence density and compared between groups as test of
incidence density ratio.
To account for statistical nonindependence of two knees
of the same patient [8, 37], we included only one knee from
any patient in the analyses of patient functional measures.
For patients with sequentially implanted bilateral TKAs in
the study, the first operated knee was included; for patients
with bilateral TKA procedures on the same day, one knee
was randomly selected (computer-generated). Survival
analyses included data of all 507 knees without account for
bilaterality [43]. There were seven unintentional occur-
rences of randomization error in the study: four knees of
four patients that were randomized to the MB system and
three knees of two patients that were randomized to the FB
system were implanted with the opposite device. Patients
who underwent revision, or who had radiographic events
used as survivorship end points, had received their allo-
cated device. To assess for possible discrepant results, we
repeated all analyses with treatment groups classified as the
device received; there were no substantive differences in
the results; therefore, groups were analyzed as randomized
unless otherwise specified. SAS/STAT software Version
9.2 (SAS Institute, Cary, NC, USA) was used for all data
analyses.
Results
No differences of WOMAC (Fig. 2), SF-12 (Fig. 3), or
Knee Society scores (Fig. 4) were found between the
groups at any postoperative interval. The MB group had
slightly greater average knee flexion at 6-month and 1-year
intervals (Fig. 5). At 1 postoperative year, 95% confidence
intervals for the estimated difference between the groups of
mean score change were within ± MCID for all functional
measures except SF-12 and WOMAC stiffness scores
(MCID defined previously as 2 extension, 5 flexion,
3 points for SF-12 scores, and 9 points for WOMAC and
Knee Society scores; Table 4); at 2 postoperative years,
they were within ± MCID for all but the WOMAC stiff-
ness score (Table 5).
Survival was similar (p = 0.351) between the groups
using revision of any component for any reason as the end
point (90.1% [95% CI, 84.1–93.9] for MB and 94.2% [95%
CI, 90.1–96.6] for FB; Fig. 6). Survival was also similar
(p = 0.952) using revision of any component or a radio-
graphic finding of radiolucency or tibial component
subsidence (described previously) as the end point (88.6%
[95% CI, 82.2–92.8] for MB and 91.3% [95% CI, 86.6–
94.4] for FB). Nineteen MB and 13 FB TKAs underwent
revision of at least one component (Table 6). For five FB
and six MB knees, the initial revision procedure was an
isolated insert revision resulting from pain (three), stiffness
(three), infection (two), instability (two), and dislocation of
a MB insert (one). Three revised patients of the MB group
Fig. 2A–C Mean WOMAC pain (A), functional impairment (B), and
stiffness (C) domain scores at pre- and postoperative evaluation
intervals. Mean scores were similar (p [ 0.05) at all intervals.
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later underwent removal of previously unrevised original
components during a second revision procedure.
Incidence of complications and nonrevision reoperations
was similar between the groups. Rates of operative site
adverse events reported for MB and FB groups were 1.6
and 1.1 per 100 person-years (p = 0.275) for major com-
plications and 14.5 and 11.9 per 100 person-years
(p = 0.061) for minor complications, respectively. A total
of 37 major and 359 minor operative site adverse events
were reported. A total of eight MB and 10 FB knees
underwent a reoperation without revision. Four MB and
five FB knees underwent closed manipulation; two of these
patients subsequently underwent arthroscopy for continued
stiffness. Six additional knees (three MB and three FB) also
underwent arthroscopic surgery, two for pain and stiffness,
three for débridement and/or synovectomy, and one for a
lateral release 8 months post-TKA for patellar subluxation.
Two knees underwent open wound irrigation and débri-
dement and/or closure secondary to wound healing
problems. One underwent open reduction and internal fix-
ation of a periprosthetic femoral fracture.
Retrieved MB devices revealed no failures of the lock-
ing rings or unexpected polyethylene wear; abrasive wear
was noted on the upper surface of only one insert.
Fig. 3A–B Mean SF-12 physical (A) and mental (B) component
normed scores at pre- and postoperative evaluation intervals. Mean
scores were similar (p [ 0.05) at all intervals.
Fig. 4A–B Mean Knee Society clinical (A) and functional (B) scores
at pre- and postoperative evaluation intervals. Mean scores were
similar (p [ 0.05) at all intervals.
Fig. 5A–B Mean active knee extension (A) and flexion (B) at pre-
and postoperative evaluation intervals. Mean differences of flexion
between groups at preoperative, 6-month, 1-year, and 2-year intervals
were 2.6 (p = 0.041), 3.5 (p = 0.008), 2.6 (p = 0.027), and 1.1
(p = 0.303), respectively.
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The remainder of the inserts demonstrated polishing without
any evidence of yellowing, cracking, or delamination. Five
inserts demonstrated mild radial scratch markings on the
underside; two demonstrated mild impingement markings
on the anterior aspects of the tibial posts. Synovial tissue
from one demonstrated extensive deposition of calcium
pyrophosphate crystals, but there was no associated abrasive
wear present on either surface of the insert.
Discussion
Given expectations that the MB TKA design should result
in improved functional rotation and stability [16, 21] and
low wear rates [2, 23, 32, 33] compared with the FB
design, we undertook this study to compare functional
measures, survivorship, and complications between groups
of patients with MB and FB devices and to report patho-
logic analysis findings of retrieved MB devices.
Limitations of our study include the following. First, we
lacked blinded observers for investigator-assessed evalua-
tions (single-blinded design). Although patient blinding
protects the outcomes measured by self-report instruments
(WOMAC and SF-12) from rater bias, the single-blind
design cannot ensure unbiased measurement of investiga-
tor-rated outcomes (ROM or Knee Society scores). Second,
we recognize this study period is not sufficient to determine
or compare long-term durability of these two implants [2,
23, 32, 33]. The study was designed and conducted for the
purpose of gaining Food and Drug Administration approval
for marketing of the device in the United States; as such,
long-term results were not required. Third, radiographic
findings are subject to measurement error, were derived
from radiographs that were not fluoroscopically guided [48],
Table 4. Change of clinical outcome scores from baseline* for 416
knees (416 patients) with fixed and mobile bearing devices at 1 year








Number evaluated 185 190
Active knee ROM (degrees)












WOMAC scores (100 points each)


















SF-12 scores (100 points each)












Knee Society scores (100 points each)










* Value given represents mean of individual patients’ change of score
from preoperative (postoperative score minus preoperative score); all
results given as mean ± SD (range); Estimated difference between
groups (mobile bearing minus fixed bearing) with 95% confidence
interval (CI).
Table 5. Change of clinical outcome scores from baseline* for 416
knees (416 patients) with fixed and mobile bearing devices at 2 years








Number evaluated 178 183
Active knee ROM (degrees)












WOMAC scores (100 points each)


















SF-12 scores (100 points each)












Knee Society scores (100 points each):












* Value given represents mean of individual patients’ change of score
from preoperative (postoperative score minus preoperative score); all
results given as mean ± SD (range); Estimated difference between
groups (mobile bearing minus fixed bearing) with 95% confidence
interval (CI).
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and were classified according to arbitrary cut points
([ 3 mm size lucency or subsidence). Fourth, there was
some loss to followup and missing data (Fig 1), although
within the commonly accepted limits of \ 15% for our
primary outcome. Fifth, the confidence interval clinical
equivalence approach depends on the correctness of the
chosen value for MCID, which is ultimately subjective. An
important strength of the confidence limit approach, how-
ever, is that one can easily compare any different threshold
with the confidence limits that one wishes.
We could identify no statistically or clinically mean-
ingful differences of postoperative WOMAC, SF-12, or
Knee Society scores between the MB and FB patient
groups of this study. These findings corroborate those of
other published randomized comparisons, which include
several prosthetic designs as well as both cruciate retaining
and substituting versions (Table 7). Average postoperative
function scores of our patient groups were similar to those
reported in other studies [20, 28, 53]. We evaluated func-
tional measures both by comparing average scores of the
groups at each interval and by estimating differences
between groups of change from preoperative score. Con-
fidence intervals for score changes were compatible with
the hypothesis of clinical equivalence between groups for
most outcomes subject to the limitations inherent in
choosing the appropriate MCID. We did observe slightly
under 4 more mean flexion at 6 and 12 postoperative
months in the MB patients, although we do not believe this
to be clinically important. This could be explained by the
occurrence, despite randomization, of a similar preopera-
tive difference and/or by the differences in the bearing
surface topography of the devices. However, the average
change of flexion from preoperatively differed by only 1
or less between the groups at every interval (Tables 4, 5),
suggesting baseline differences may be implicated.
Midterm survivorship was similar between the MB and
FB groups of this study; however, the overall revision rate
(32 of 507 knees [6%]) is slightly higher than those
reported in other series of MB or FB posterior stabilized
devices [1, 26–28, 36, 40]. This could be explained in part
by the stringent evaluation process of the Investigational
Device Exemption and/or the fact that the study included a
large number of participating sites with varying levels of
experience with knee arthroplasty. Similar tendencies have
been noted in other randomized comparisons [26, 28, 41].
The most common reasons for revision of these patients
were pain and stiffness, which accounted for over half (18
of 32).
The overall rates of minor and major complications,
some of which required surgical reoperations (nonrevi-
sion), were similar to those reported from other randomized
evaluations [26, 36] and did not appear to be design-related.
A large single-surgeon retrospective series of an FB device
similar to the FB device studied here reported lower rates
of revisions and complications [30]; however, the surveil-
lance and scrutiny applied to an observational cohort is
typically less rigorous than that applied to patients of an
Investigational Device Exemption. It is also well recog-
nized that patients who participate in experimental clinical
trials differ from general populations of patients in ways
that can be associated with general health behavior and
outcomes [44].
Table 6. Numbers of knees undergoing revision, components
revised, and reasons for revision among fixed and mobile bearing
















Femoral component 8 5
Tibial component 14 7
Patellar component 3 1
Tibial insert 19 13
* Reason for the first revision procedure to the knee; numbers of
components implanted during primary TKA that were removed dur-
ing the course of the study.
Fig. 6 Kaplan-Meier survival curves are shown for fixed and mobile
bearing groups with numbers at risk shown at yearly intervals. End
point for the analysis was any component no longer in situ for any
reason. Estimated survival probabilities at 6 postoperative years were
94.2% (95% confidence interval [CI], 90.1–96.6) for fixed bearing
devices and 90.1% (95% CI, 89.1–93.9) for mobile bearing devices
with 56 and 53 at-risk subjects remaining, respectively. Survival
curves were similar (p = 0.351).
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Retrieval analysis of explanted MB specimens revealed
no unexpected wear patterns or evidence of device failure
mechanism. Two specimens showed small anterior
impingement marks seen on the anterior aspect of the tibial
posts; this finding has been noted previously in this and
other posterior stabilized devices [34, 46] and its clinical
relevance remains uncertain.
In conclusion, we found no short-term functional
advantage to a rotating bearing knee arthroplasty, although
questions regarding potential durability advantages remain
and require longer observation.
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